(Q37678245)

21 August 2017

1 reference

title

Update multiple endocrine neoplasia type 2. (English)

1 reference

multiple endocrine neoplasia

21 August 2017

main subject

1 reference

Friedhelm Raue

1

1 reference

21 August 2017

Karin Frank-Raue

series ordinal

2

1 reference

21 August 2017

publication date

1 September 2010

1 reference

21 August 2017

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

449-457

1 reference

Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.

21 August 2017

cites work

1 reference

12 December 2020

Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence

1 reference

12 December 2020

Germline mutation of RET codon 883 in two cases of de novo MEN 2B.

1 reference

12 December 2020

Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family

1 reference

12 December 2020

Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium

1 reference

12 December 2020

German medullary thyroid carcinoma/multiple endocrine neoplasia registry. German MTC/MEN Study Group. Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2.

1 reference

12 December 2020

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

12 December 2020

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 reference

12 December 2020

Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.

1 reference

12 December 2020

Medullary thyroid cancer: monitoring and therapy

1 reference

12 December 2020

Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases.

1 reference

12 December 2020

Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791.

1 reference

12 December 2020

Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2.

1 reference

12 December 2020

A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A

1 reference

12 December 2020

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

1 reference

12 December 2020

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

1 reference

12 December 2020

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems

1 reference

12 December 2020

Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinoma

1 reference

12 December 2020

Change in the spectrum of RET mutations diagnosed between 1994 and 2006

1 reference

12 December 2020

Pheochromocytoma penetrance varies by RET mutation in MEN 2A

1 reference

12 December 2020

Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis.

1 reference

12 December 2020

Multiple endocrine neoplasia type 2. Clinical features and screening.

1 reference

12 December 2020

The Natural Course of Multiple Endocrine Neoplasia Type iib

1 reference

12 December 2020

RET mutations in exons 13 and 14 of FMTC patients

1 reference

12 December 2020

Long-term follow-up of patients with medullary carcinoma of the thyroid

1 reference

12 December 2020

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

1 reference

12 December 2020

Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers.

1 reference

12 December 2020

Medullary thyroid cancer: management guidelines of the American Thyroid Association

1 reference

12 December 2020

Evidence-based approach to the management of sporadic medullary thyroid carcinoma

1 reference

12 December 2020

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

1 reference

12 December 2020

Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).

1 reference

12 December 2020

Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin

1 reference

12 December 2020

C cell hyperplasia/neoplasia

1 reference

12 December 2020

Germ-line mutations in nonsyndromic pheochromocytoma

1 reference

12 December 2020

Determinants of life expectancy in medullary thyroid cancer: age does not matter.

1 reference

12 December 2020

A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10

1 reference

12 December 2020

Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times

1 reference

12 December 2020

Early Malignant Progression of Hereditary Medullary Thyroid Cancer

1 reference

12 December 2020

RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors

1 reference

12 December 2020

Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype

1 reference

12 December 2020

Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group

1 reference

12 December 2020

10.1007/S10689-010-9320-2

Identifiers

DOI

1 reference

21 August 2017

1 reference